Maneewannakul K, Levy S B
Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Antimicrob Agents Chemother. 1996 Jul;40(7):1695-8. doi: 10.1128/AAC.40.7.1695.
Quinolone-resistant clinical Escherichia coli isolates were examined for mutations in the marRAB operon of the multiple antibiotic resistance (mar) locus. Among 23 strains evaluated, 8 were chosen for further study: 3 that showed relatively high levels of uninduced, i.e., constitutive, expression of the operon and 5 with variable responses to induction by salicylate or tetracyclines. The marR genes, specifying the repressor of the operon, cloned from the three strains constitutively expressing the operon did not reduce the level of expression of beta-galactosidase from a marO::lacZ transcriptional fusion and were therefore mutant; however, marR genes cloned from the five other clinical strains repressed LacZ expression and were wild type. All three mutant marR genes contained more than one mutation: a deletion and a point mutation. Inactivation of the mar locus in the three known marR mutant strains with a kanamycin resistance cassette introduced by homologous recombination reduced resistance to quinolones and multiple antibiotics. These findings indicate that mar operon mutations exist in quinolone-resistant clinical E. coli isolates and contribute to quinolone and multidrug resistance.
对耐喹诺酮类的临床大肠杆菌分离株进行了多重耐药性(mar)位点的marRAB操纵子突变检测。在评估的23株菌株中,选择了8株进行进一步研究:3株表现出相对较高水平的未诱导型(即组成型)操纵子表达,5株对水杨酸盐或四环素诱导的反应各不相同。从组成型表达操纵子的三株菌株中克隆的、编码操纵子阻遏物的marR基因,并未降低来自marO::lacZ转录融合体的β-半乳糖苷酶的表达水平,因此是突变型;然而,从其他五株临床菌株克隆的marR基因抑制了LacZ表达,是野生型。所有三个突变的marR基因都包含不止一个突变:一个缺失和一个点突变。通过同源重组引入卡那霉素抗性盒,使三个已知的marR突变菌株中的mar位点失活,降低了对喹诺酮类和多种抗生素的抗性。这些发现表明,耐喹诺酮类的临床大肠杆菌分离株中存在mar操纵子突变,并导致对喹诺酮类和多药耐药。